The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Clearance of Vykat unlocks what analysts anticipate will be a lucrative market opportunity for Soleno Therapeutics.
The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results